Sakurai T, Fujita T, Kono I, Kabashima T, Yamane K, Tamura N, Kashiwagi H
Clin Exp Immunol. 1982 Apr;48(1):37-42.
The capacity of complement-mediated solubilization of immune complexes (complex releasing activity: CRA) was studied in 63 sera from eight systemic lupus erythematosus (SLE) patients. CRA in sera of active SLE (35 +/- 17.%) was significantly lower than that of inactive SLE (64.1 +/- 24.1%, P less than 0.001). In addition, 20 of 23 sera collected during active diseases demonstrated CRA values less than 50% of the control pooled serum. On the other hand, CRA of 29 of 40 sera from inactive disease exceeded the 50% level. CRA in SLE sera correlated with complement component levels and in particular with the CH50. Serial determination of CRA and of levels of circulating immune complexes (CIC), C4 and C3 in two active patients indicated that the correlation between CRA and the complement components was positive, while that between CRA and CIC was negative. These studies provide evidence that CRA may be useful for following the activity of SLE and that CRA reflects the levels of the complement components of both classical and alternative pathways. The possibility that CIC may be solubilized and opsonized by complement and cleared by the reticuloendothelial system was discussed.
对8例系统性红斑狼疮(SLE)患者的63份血清进行了补体介导的免疫复合物溶解能力(复合物释放活性:CRA)研究。活动期SLE患者血清中的CRA(35±17.%)显著低于非活动期SLE患者(64.1±24.1%,P<0.001)。此外,在疾病活动期采集的23份血清中有20份的CRA值低于对照混合血清的50%。另一方面,非活动期疾病的40份血清中有29份的CRA超过50%水平。SLE血清中的CRA与补体成分水平相关,尤其是与CH50相关。对两名活动期患者的CRA以及循环免疫复合物(CIC)、C4和C3水平进行连续测定表明,CRA与补体成分之间呈正相关,而CRA与CIC之间呈负相关。这些研究提供了证据,表明CRA可能有助于监测SLE的活动情况,并且CRA反映了经典途径和替代途径的补体成分水平。讨论了CIC可能被补体溶解、调理并被网状内皮系统清除的可能性。